This editorial focuses on the use of Micro total analysis systems (μTAS) in the biopharmaceutical industry and how new partnerships can lead to its full implementation.
This editorial provides an overview of various factors that have affected bioanalysis negatively. Recession is one of the factors that is looked at in more depth.
Urgent need to develop independent biomarkers for functional, diagnostic and prognostic application in oncology research
This editorial highlights the need for new, independent biomarkers in oncology.
This editorial highlights the importance of collaborations between members of the bioanalytical community i.e including regulatory organisations, scientists etc.
This commentary provides a brief review of the 2008 EMA paper on bioanalytical method validation.
This editorial provides a summary of the history of metabolites in safety testing (MIST).
This commentary outlines the utilisation of a promising miniaturized SPE technique in bioanalysis.
This editorial focuses on the possible implementation of therapeutic drug monitoring (TDM) in oncology.
This editorial outlines how hugely significant Bioanalysis is and will be for the scientific community.
This editorial highlights some of the risks associated with biomarker analysis in clinical drug development.